Congratulations!

At the Annual Scientific Symposium of the Fondation Maladies Rares, the Alnylam was given to Christine Labreze and François Moisan (Team 05 – Translational research in cutaneous oncology and rare skin diseases – TRIO2), for their project “Interfering RNA approach targeting the mutation of the GNAQ gene in vascular anomalies”.